CHO Pharma, Inc. (6586.TWO)
TWD 53.5
(0.38%)
TWD 53.5
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -291.12 Million | -249.5 Million | -193.46 Million | -248.72 Million | -266.71 Million |
| Net Income | -306.08 Million | -338.39 Million | -205.92 Million | -296.83 Million | -358.37 Million |
| Depreciation & Amortization | 28.27 Million | 39.85 Million | 39.08 Million | 41.24 Million | 34.05 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | -7.65 Million | 21.99 Million | -13.84 Million | -5.01 Million | 1.02 Million |
| Change in working capital | -56.38 Million | 27.05 Million | -18.79 Million | 11.79 Million | -2.03 Million |
| Other non-cash items | -16.16 Million | -6.75 Million | -4.88 Million | -7.33 Million | 58.61 Million |
| Investing Cash Flow | -1.85 Billion | -9.01 Million | -3.02 Million | -19.04 Million | -16.86 Million |
| Investments in PPE | -2 Million | -9.39 Million | -2.64 Million | -22.16 Million | -11.43 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -1.86 Billion | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 2.56 Million | 386 Thousand | -385 Thousand | 3.11 Million | -5.42 Million |
| Financing Cash Flow | 1.84 Billion | -13.89 Million | -11.31 Million | -9.59 Million | 8.81 Million |
| Debt repayment | -11.69 Million | -14.39 Million | -12.51 Million | -12.23 Million | -4.97 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.86 Billion | 500 Thousand | 1.2 Million | 2.64 Million | - |
| Other Financing Activities | 1.86 Billion | 500 Thousand | 1.2 Million | 2.64 Million | 13.79 Million |
| Accounts receivables | - | 63 Thousand | -63 Thousand | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -3.7 Million | -11.24 Million | -2.25 Million | -2.81 Million | -2.03 Million |
| Cash at beginning of period | 505.65 Million | 777.98 Million | 986.38 Million | 1.26 Billion | 1.54 Billion |
| Cash at end of period | 203.79 Million | 505.65 Million | 777.98 Million | 986.38 Million | 1.26 Billion |
| Capital Expenditure | -2 Million | -9.39 Million | -2.64 Million | -22.16 Million | -11.43 Million |
| Effect of forex changes on cash | 48 Thousand | 87 Thousand | -597 Thousand | -711 Thousand | -1.87 Million |
| Net cash flow / Change in cash | -301.86 Million | -272.32 Million | -208.4 Million | -278.07 Million | -276.63 Million |
| Free Cash Flow | -293.12 Million | -258.9 Million | -196.1 Million | -270.88 Million | -278.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -49.98 Million | -49.98 Million | -306.08 Million | -77.63 Million | -77.63 Million | -75.4 Million |
| Depreciation & Amortization | 6.37 Million | 6.37 Million | 28.27 Million | 6.9 Million | 6.9 Million | 7.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 561.5 Thousand | - | -7.65 Million | -3.5 Million | -3.5 Million | -320.5 Thousand |
| Change in working capital | -2.05 Million | -2.05 Million | -56.38 Million | -898.5 Thousand | -898.5 Thousand | -955 Thousand |
| Other non-cash items | -6.03 Million | -5.47 Million | -16.16 Million | 3.56 Million | 3.56 Million | -4.53 Million |
| Investing Cash Flow | 11.6 Million | 11.6 Million | -1.85 Billion | -930.53 Million | -930.53 Million | 815.5 Thousand |
| Investments in PPE | -1.94 Million | -1.94 Million | -2 Million | -480.5 Thousand | -480.5 Thousand | -519.49 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -1.86 Billion | - | - | - |
| Sales/Maturities of investments | 27 Million | - | - | - | - | - |
| Other Investing Activities | 13.55 Million | 13.55 Million | 2.56 Million | -930.05 Million | -930.05 Million | 1.33 Million |
| Financing Cash Flow | -3.49 Million | -3.49 Million | 1.84 Billion | 927.23 Million | 927.23 Million | -2.91 Million |
| Debt repayment | - | - | -11.69 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.86 Billion | - | - | - |
| Other Financing Activities | -3.49 Million | -3.49 Million | 1.86 Billion | 927.23 Million | 927.23 Million | -2.91 Million |
| Accounts receivables | -210 Thousand | -210 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.84 Million | -1.84 Million | -3.7 Million | -898.5 Thousand | -898.5 Thousand | -955 Thousand |
| Cash at beginning of period | 203.79 Million | - | 505.65 Million | - | - | - |
| Cash at end of period | -43.01 Million | -43.01 Million | 203.79 Million | -74.85 Million | -74.85 Million | -76.07 Million |
| Capital Expenditure | -1.94 Million | -1.94 Million | -2 Million | -480.5 Thousand | -480.5 Thousand | -519.49 Thousand |
| Effect of forex changes on cash | 18 Thousand | 18 Thousand | 48 Thousand | 17.5 Thousand | 17.5 Thousand | 6500.00 |
| Net cash flow / Change in cash | -246.8 Million | -43.01 Million | -301.86 Million | -74.85 Million | -74.85 Million | -76.07 Million |
| Free Cash Flow | -53.08 Million | -53.08 Million | -293.12 Million | -72.05 Million | -72.05 Million | -74.5 Million |
BHANDARI
COIC
CARA
COGN3
FIV
KOTHARIPRO